Ana Sabsil Lopez Rocha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Sabsil Lopez Rocha has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aitana Sogorb-Esteve
Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
1 shared publication Alexandra König
CoBteK (Cognition-Behaviour-Technology) lab, Université Côte d’Azur, Nice, France
1 shared publication- Alina Solomon
University of Eastern Finland
1 shared publication - Anna Matton
Karolinska Institutet
1 shared publication - Anna Rosenberg
University of Eastern Finland
1 shared publication Aram Aslanyan
Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 18 (1)
Clinical translation of fluid, imaging, and digital biomarkers for Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting millions worldwide. The clinical presentation of AD is heterogenous
- 9 January 2026
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 18 (1)
Open AccessClinical translation of fluid, imaging, and digital biomarkers for Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting millions worldwide. The clinical presentation of AD is heterogenous
- Open Access
- 23 June 2025
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 20 (1) , 1-22
Mechanisms of interventions targeting modifiable factors for dementia risk reduction
The global prevalence of dementia is increasing. With no widely available and accessible treatments to halt or reverse the progression of dementia, exploring preventative strategies is critical. Lifestyle-based interventions show promise in preventing or delaying dementia onset. However, understanding the complex and multifactorial mechanisms underlying dementia, and how interventions target these pathways, is essential for developing personalized and effective strategies. In this review, we examined the current evidence of the mediating pathways in dementia risk reduction. We focused on mechanisms investigated in single-domain interventions on physical exercise, cognitive training, diet, metabolic/cardiovascular or psycho-social risk factors in line with those combined in the landmark FINGER trial. Additionally, we synthesized existing literature on mechanisms of action in multimodal interventions combining multiple lifestyle changes. Most evidence was identified in relation to neuroimaging biomarkers with positive effects for all intervention components. The evidence among fluid biomarkers of Alzheimer’s disease and related disorders (ADRD) (amyloid-beta peptide (Aβ), tau and neurofilament light chain (Nfl)) vascular markers, inflammatory markers, and neurotrophins were less conclusive, though physical exercise consistently appeared to impact several of these pathways. The findings of this review underscore the potential of lifestyle-based interventions in modulating several different types of pathophysiological pathways associated with dementia. As the number of dementia cases reach epidemic proportions, a multifaceted approach is needed. We propose that the next critical step in dementia prevention/risk reduction is to refine existing intervention tools and develop an adaptive platform that integrates different lifestyle interventions tailored to individual risk profiles and needs. Understanding the underlying mechanisms and biomarkers related to modifiable risk factors will be instrumental to optimising these interventions.
- 23 June 2025
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 20 (1) , 1-22
Open AccessMechanisms of interventions targeting modifiable factors for dementia risk reduction
The global prevalence of dementia is increasing. With no widely available and accessible treatments to halt or reverse the progression of dementia, exploring preventative strategies is critical. Lifestyle-based interventions show promise in preventing or delaying dementia onset. However, understanding the complex and multifactorial mechanisms underlying dementia, and how interventions target these pathways, is essential for developing personalized and effective strategies. In this review, we examined the current evidence of the mediating pathways in dementia risk reduction. We focused on mechanisms investigated in single-domain interventions on physical exercise, cognitive training, diet, metabolic/cardiovascular or psycho-social risk factors in line with those combined in the landmark FINGER trial. Additionally, we synthesized existing literature on mechanisms of action in multimodal interventions combining multiple lifestyle changes. Most evidence was identified in relation to neuroimaging biomarkers with positive effects for all intervention components. The evidence among fluid biomarkers of Alzheimer’s disease and related disorders (ADRD) (amyloid-beta peptide (Aβ), tau and neurofilament light chain (Nfl)) vascular markers, inflammatory markers, and neurotrophins were less conclusive, though physical exercise consistently appeared to impact several of these pathways. The findings of this review underscore the potential of lifestyle-based interventions in modulating several different types of pathophysiological pathways associated with dementia. As the number of dementia cases reach epidemic proportions, a multifaceted approach is needed. We propose that the next critical step in dementia prevention/risk reduction is to refine existing intervention tools and develop an adaptive platform that integrates different lifestyle interventions tailored to individual risk profiles and needs. Understanding the underlying mechanisms and biomarkers related to modifiable risk factors will be instrumental to optimising these interventions.